Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

3,256 evidence items · page 8 / 131

87.7 %Les adénopathies supérieures à un centimètre représentaient 87,7 % des adénopathies malignes.

Gabonadénopathies malignespublished 2018Health sciences and diseaseOpenAlexdocument of 9 observations

150 mf/mLThe median Loa loa parasitaemia in people living with HIV receiving cotrimoxazole prophylaxis was 150 mf/mL (interquartile range 125–350).

Gabonloasepublished 2022Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument of 10 observations

44 %The overall prevalence of soil-transmitted helminth (STH) infections was 44% at baseline for the nine-month follow-up period.

Gabonsoil-transmitted helminth (STH) infectionspublished 2024Tropical medicine and healtheurope_pmcdocument of 9 observationsDOI 10.1186/s41182-023-00567-z

40.1 odds_ratioChildren living on or near the Mindoubé landfill site were more likely to develop ENT pathology with an odds ratio of 40.1.

GabonENT pathologypublished 2024Asian Journal of Pediatric ResearchOpenAlexdocument of 5 observationsDOI 10.9734/ajpr/2024/v14i1318

69.6 %Malaria infection prevalence was 69.6% among school-aged children in Gabon.

Gabonpaludismeobserved 2021published 2024Tropical medicine and infectious diseaseeurope_pmcdocument of 8 observationsDOI 10.3390/tropicalmed10010011

59 %After 28 days, 59% of participants in the Individual Treatment group were clinically cured.

Gabonscabiespublished 2020PLoS neglected tropical diseaseseurope_pmcdocument of 4 observationsDOI 10.1371/journal.pntd.0008423

45.9 %For low-level parasitemias, venous blood microscopy sensitivity dropped to 45.9%.

Gabonpaludismeobserved 2015–2016published 2018The Journal of infectious diseaseseurope_pmcdocument of 8 observationsDOI 10.1093/infdis/jiy319

4.7 %Subtype F accounted for 4.7% of HIV-1 cases in the studied population in Gabon.

GabonVIH/sidapublished 2012BMC Infectious DiseasesOpenAlexdocument of 14 observationsDOI 10.1186/1471-2334-12-64

10.3 %The wild-type D1246 Pfmdr1 genotype prevalence was 10.3% in symptomatic infections and 100% in asymptomatic infections.

Gabonpaludismepublished 2021Infection and drug resistanceeurope_pmcdocument of 10 observationsDOI 10.2147/idr.s304361

4 %In an efficacy open-label clinical trial with a 28-day follow-up in 29 children under five with uncomplicated malaria, PCR-corrected, 1/26 (4%) had an early treatment failure, resulting in early trial discontinuation.

Gabonpaludismepublished 2011Malaria journaleurope_pmcdocument of 5 observationsDOI 10.1186/1475-2875-10-123

78.8 %In study A, the specificity of the Schistoscope was 78.8% based on the composite reference standard.

Gabonschistosomiasepublished 2024PLoS neglected tropical diseaseseurope_pmcdocument of 10 observationsDOI 10.1371/journal.pntd.0011967

36.4 %The therapeutic success rate among pre-XDR patients was 4 (36.4%).

Gabonpre-XDR TBobserved 2019 to 2022published 2024Revue des maladies respiratoiresPubMeddocument of 15 observations

The cumulative HPV viral loads of any HPV and high-risk HPV in ICC were significantly higher than those in CIN2/3 (p < 0.002 for any HPV; p = 0.02 for HR-HPV).

Gabonhigh-risk HPV · ICC · infection à HPV · lésions précancéreuses du col (CIN)published 2025Health science reportsPubMeddocument of 3 observations

2.2 odds_ratioThe association between high blood pressure and diabetes significantly increased the risk of death in heart failure patients (OR = 2.2, 95% CI: 1.2–6.6).

Gabondiabète (non précisé) · hypertension artérielle · insuffisance cardiaqueobserved January 2014 to December 2016published 2018The Pan African medical journalPubMeddocument of 9 observations

20,000,000 infectionsMore than 20 million people are infected with L. loa.

GabonL. loa · loasepublished 2024PLoS neglected tropical diseaseseurope_pmcdocument of 7 observations

20 copiesThe RT-LAMP assay successfully detected 20–50 copies of the SARS-CoV-2 viral genome within 15 minutes, regardless of the variant.

GabonCOVID-19published 2022PLoS neglected tropical diseaseseurope_pmcdocument of 3 observationsDOI 10.1371/journal.pntd.0010964

6.5 %Vaccine efficacy of GMZ2/alum was 6.5% against clinical malaria over 24 months in the intention-to-treat analysis.

Gabonpaludismepublished 2021VaccinePubMeddocument of 3 observations

1.2 %Human coronavirus OC43 was detected in 1.2% of the 156 respiratory virus-positive nasopharyngeal swab specimens collected in Gabon from March 2020 to July 2021.

Gabonhuman coronavirus OC43observed March 2020 to July 2021published 2024Viruseseurope_pmcdocument of 8 observations

24.6 %WNV-specific IgG prevalence was 24.6% in females in Gabon.

GabonWest Nile viruspublished 2010Virology JournalOpenAlexdocument of 6 observationsDOI 10.1186/1743-422x-7-132

31 yearsThe mean and median age of the patients was 31 years in the study on vulvovaginal candidiasis near Franceville, Gabon.

Gabonvulvovaginal candidiasispublished 2023Journal de mycologie medicaleeurope_pmcdocument of 3 observations

52.8 %Le motif de l’avortement était une grossesse non désirée dans 52,8 % des cas d’avortement clandestin au Centre Hospitalier Universitaire de Libreville entre 2014 et 2018.

Gabonavortement clandestinobserved 2014 à 2018published 2021Revue de médecine et de pharmacieOpenAlexdocument of 24 observations

0.45 adjusted_odds_ratioParity was associated with Plasmodium falciparum infection, with an adjusted odds ratio of 0.45 for multipara versus paucipara.

Gabonpaludismeobserved 2008–2011published 2013Malaria JournalOpenAlexdocument of 6 observationsDOI 10.1186/1475-2875-12-412

20.75 %The global mixed rate of infections among infected individuals was 20.75% (11/53).

Gabonmixed trypanosome infectionpublished 2022Pathogens (Basel, Switzerland)europe_pmcdocument of 6 observationsDOI 10.3390/pathogens11090992

329 participantsAscaridiasis was present in 329 participants (43.0%).

GabonascariasisHAL · Unilimdocument of 153 observations

3.7 %Microfilariae were associated with increased moderate anemia (3.7% vs. 29%).

Gabonmicrofilaremia · moderate anaemiaobserved March 2018 to October 2019published 2024Balkan medical journaleurope_pmcdocument of 7 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.